Form 4: Neumora Therapeutics CFO Transfers Ownership of Shares for Estate Planning

Joshua Pinto, CFO of Neumora Therapeutics, reports a transfer of shares to a family limited liability company and subsequent transfer of membership interests to a trust for estate planning purposes.

Summary

• On April 17, 2024, Joshua Pinto, the Chief Financial Officer of Neumora Therapeutics, reported a transaction involving the transfer of membership interests in a family limited liability company (Family LLC) to a trust.
• The Family LLC holds 238,965 shares of Neumora Therapeutics common stock.
• The transfer of membership interests was made for estate planning purposes and involved no consideration.
• Mr. Pinto retains investment control over the common stock held by the Family LLC.
• Mr. Pinto also directly owns 85,000 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a transfer of shares for estate planning purposes. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes.

Related Party Transactions

• The transfer of shares to a family limited liability company and subsequent transfer of membership interests to a trust are related-party transactions.

Stakeholder Impact

• The transaction itself is unlikely to have a direct impact on stakeholders, as it is primarily for estate planning purposes and does not change the CFO's control over the shares.

Key Dates